Pfizer (PFE) CFO Dave Denton to Depart; Cecile Guegan Named Interim Finance Chief

Pfizer Inc. (PFE) announced June 18, 2026, that Chief Financial Officer Dave Denton will step down from his position. The pharmaceutical giant has appointed Cecile Guegan as interim finance chief, effective immediately. Guegan, who currently serves as Senior Vice President and Controller, will assume the interim CFO role while Pfizer conducts a search for a permanent successor. Denton's departure marks a significant leadership change for the company.